Clarity PharmaceuticalsSubscribe to Clarity Pharmaceuticals

International radiopharmaceutical company Clarity has licensed technology developed at the University of Melbourne for imaging and treating prostate cancer.

Pharmaceuticals that seek out cancerous cells and deliver treatments to them; imaging techniques that can help doctors detect diseases before the physical signs begin to appear; and medicines that are tailor-made for individual patients, are within the sights of an exciting new start-up venture.